Effect of Intravenous Fluid therapy on Serum level of Bilirubin in icteric neonates during phototherapy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2013022711145N5

Enrollment

100

Registered

2013-03-26

Start date

2013-03-21

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neonatal jaundice. Neonatal jaundice due to unspecified causes

Interventions

Intervention 1: Control: only phototherapy without intravenous fluid. Intervention 2: Intervention: Intravenous fluids containing dextrose 10% equal amounts of maintenance with 30 mEq/L sodium and 20

Treatment - Drugs

Control: only phototherapy without intravenous fluid

Intervention: Intravenous fluids containing dextrose 10% equal amounts of maintenance with 30 mEq/L sodium and 20 mEq/L potassium plus phototherapy

Eligibility

Sex/Gender

All

Age

1 Years to 14 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Gestational age > 38 weeks; age > 24 hours on admission; serum level of total bilirubin > 15 mg/dl; indirect hyperbilirubinemia Exclusion criteria: Necessery to fluid therapy except icter; preterm and LBW neonates; hemolytic jaundice; sepsis; prolonged icter

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Serum bilirubin level. Timepoint: on admission, 6-12-24 hours later. Method of measurement: Blood test.	—

Secondary

Measure	Time frame
Duration of phototherapy. Timepoint: During hospitalization. Method of measurement: Calculating the hours of phototherapy.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr.Mohammad Reza Sharif

Kashan University of Medical Sciences

mrsharifmd@yahoo.com+98 36 1555 0026

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026